Target intelligence / Profile preview

Ocular fundus chromophore

Molecular classification
Pigment, Small molecule, Cofactor, Lipid-derived molecule
01

Overview

Ocular fundus chromophores are a diverse group of light-absorbing molecules located in the posterior segment of the eye, primarily within the retina, retinal pigment epithelium (RPE), and choroid. This collective term encompasses endogenous pigments such as rhodopsin and cone opsins, which are essential for phototransduction, as well as melanin, which provides photoprotection and heat dissipation. It also includes macular pigments like lutein and zeaxanthin that filter high-energy blue light, and hemoglobin, which is responsible for oxygen transport in ocular vessels. Additionally, the group includes age-related metabolic byproducts such as lipofuscin (specifically the fluorophore A2E), which can become phototoxic upon accumulation. These chromophores are central to both normal visual function and the pathogenesis of various retinal degenerations, such as age-related macular degeneration (AMD) and Stargardt disease, where the accumulation of toxic byproducts leads to RPE cell death. Therapeutic strategies often involve modulating the visual cycle to reduce the formation of toxic chromophores or utilizing nutritional supplements to bolster protective pigments.

Other names
Retinal chromophoresOcular pigmentsVisual pigmentsFundus fluorophoresPosterior segment chromophores
02

Mechanism of action

Visual cycle modulation to reduce toxic lipofuscin accumulation; antioxidant supplementation to increase macular pigment density; photodynamic therapy using exogenous chromophores; drug sequestration via melanin binding.

03

Biological functions

PhototransductionLight absorptionPhotoprotectionAntioxidant activityOxygen transportThermal regulation
04

Disease associations

Age-related macular degenerationStargardt diseaseRetinitis pigmentosaDiabetic retinopathyChoroidal neovascularization
05

Safety considerations

Delayed dark adaptationNight blindnessRetinal pigment epithelium toxicityPhototoxicityIrreversible retinal pigmentation
06

Interacting drugs

Emixustat

6 more in the full profile.

07

Biomarkers

Fundus autofluorescence (FAF)Macular pigment optical density (MPOD)Ocular oximetryRetinal reflectometry

Beyond the preview

Go deeper on Ocular fundus chromophore.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ocular fundus chromophore.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call